The World Health Organization has added “lifesaving” interleukin-6 receptor blockers to its list of treatments for COVID-19 – only the second drugs to be recommended as effective against the disease – as the pandemic continues to accelerate across the world. “These drugs offer hope for patients and families who are suffering from the devastating impact of severe and critical COVID-19,” …
Observing that no assurance was given by Roche India, which enjoys the license of manufacturing Tocilizumab 400 mg, if any further stock can be supplied to India, the Delhi High Court on Thursday sought Centre's response on the demand of the said drug and how does the Centre intend to obtain the supplies of the said drug through Roche India …
There is yet no evidence from trials that itolizumab and tocilizumab, two drugs, one of which has been developed by Bengaluru-based Biocon Biologics, reduce death in severely ill coronavirus patients, Director-General of the ICMR Balram Bhargava said at a Health Ministry press briefing on Tuesday. Biocon’s COVID-19 drug tested on too few patients to reliably conclude on benefits, say experts …
